An Updated Overview of Cyclodextrin-Based Drug Delivery Systems for Cancer Therapy
Cyclodextrins (CDs) attracted increasing interest over the past few years, leading to the emergence of promising anti-tumor nanomedicines. Tackling their
Tag: targeting
SBEβCD-based nanodelivery system targeting the brain
Neuroinflammation occurs early in Alzheimer’s disease (AD). The initial stage of AD is related to glial dysfunction, which contributes to
Twenty years of research on cyclodextrin conjugates with PAMAM dendrimers
Cyclodextrin (CD) conjugates with starburst polyamidoamine (PAMAM) dendrimer (CDEs), as a new type of polymer-based carriers, were first published in
Adjusting the Structure of β-cyclodextrin to Improve Complexation of Anthraquinone-derived Drugs
A nice example for the tailor-made CD derivatives: CD derivatives containing aromatic triazole ring were studied as potential carriers of
A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment
A novel folate receptor-targeted β-cyclodextrin drug delivery vehicle was constructed to improve the bioavailability, biosafety, and drug loading capacity of
Symposium of Drug Delivery Systems – 2020 (SDDS-2020) Postponed to 2021 (SDDS-2021)
The 9th Annual International Symposium of Drug Delivery Systems – 2020 (SDDS-2020) which will was originally planned during July 15-17,
Symposium of Drug Delivery Systems – 2020 (SDDS-2020)
The 9th Annual International Symposium of Drug Delivery Systems – 2020 (SDDS-2020) which will be held during July 15-17, 2020
In vivo preclinical evaluation of the new 68Ga-labeled beta-cyclodextrin in prostaglandin E2 (PGE2) positive tumor model using positron emission tomography
The cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) pathway plays an important role in tumor development and formation of metastases. It was earlier
Drug in CD in liposome for targeted delivery of anti-tubercular drugs
Nkanga and Krause have published in Nature Scientific Reports their recent development of a novel anti-tubercular drug delivery system. Isoniazid-hydrazone-phthalocyanine
Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery
In the laboratory of C. M. O’Driscoll (University College Cork), an antibody targeted cyclodextrin-based siRNA delivery vector (CD.DSPE-PEGFab) was developed